Precise
PRECISE, Temus form center to support Singapore’s genome program’s Phase III
Singapore's national precision-medicine agency (PRECISE) and Temasek-backed technology firm Temus will jointly build the data and computing systems for the next phase of the country's effort to sequence hundreds of thousands of residents' genomes.
Convergence in the blood: How AI and biotech are rewriting cancer detection across Asia
Industrial bases, not just science, will determine whether breakthroughs become real benefits.
